Immunomedics Awarded Additional U.S. Patent for Anti-CD20 Treatment of Autoimmune Diseases
Immunomedics Awarded Additional U.S. Patent for Anti-CD20 Treatment of Autoimmune Diseases
MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other …